Preclinical Bioscience CRO Services for Early stage Drug Discovery
Generate decision-ready in vitro data with confidence
BioMedha is a UK-based preclinical contract research organisation (CRO) supporting biotechnology and pharmaceutical companies with high-quality in vitro assays. We help drug discovery teams validate targets, compound profiling, understand mechanisms of action, and identify potential risks early – so programmes move forward faster and with clarity.
Accelerating your drug discovery
CRO services designed to support real decisions
BioMedha offers a portfolio of preclinical research bioscience CRO services, designed to support programmes at early stage discovery.
- Small, flexible CRO team delivering bespoke assay solutions
- Direct access to bench scientists - no account layers
- Decision-ready in vitro data aligned to discovery milestones
- UK-based CRO supporting global biotech and pharma teams
Immunology studies
Immunology studies
Find out moreFlow cytometry
Flow cytometry
Find out moreGPCR assays
GPCR assays
Find out moreExpression studies
Expression studies
Find out moreCell imaging
Cell imaging
Find out moreDiscovery toxicology
Discovery toxicology
Find out moreWe bring extensive drug discovery biology expertise in:
- Immunology, oncology, immuno-oncology, and inflammation therapeutic areas
- Hypothesis testing, target validation, assay development, and screening from hit to lead and through to candidate selection
- Whole blood assays and immune cell assays
- Flow cytometry analysis
- Cytokine assays and Immunogenicity assessment
- Cell imaging
- Expression studies (protein, mRNA, secretion, surface expression)
- Functional assays (cytokines, bioassays, receptor, and signaling pathways)
- GPCR assay development and screening
- Protein-protein interactions
- Mechanism of action studies
- Discovery toxicology studies
- Biochemical assays
Robust In vitro assays are the foundation of effective drug discovery pipelines, and our custom assay development and screening services provide you with consistent performance. BioMedha facilitates the development of such assays across multiple platforms for your project needs.
WHY WORK WITH BIOMEDHA
Our friendly and highly flexible team of bioscientists bring the expertise needed to help accelerate your drug discovery project.
Bespoke, issue-specific, high-quality services tailored to meet your project objectives
Reliable, quick turnaround times and strict quality controls
Most competitive pricing, offering significant cost savings
On-time delivery
Direct and prompt communication with bench scientists